Do age and comorbidity impair recovery during two years after treatment for endometrial cancer?
- van Walree, Inez C
- Hamaker, Marije E
- de Rooij, Belle H
- Boll, Dorry
- van Huis-Tanja, Lieke H
- Emmelot-Vonk, Marielle H
- Ezendam, Nicole P M
DOIAbstract
Background: A better understanding of the impact of age and comorbidity on health-related quality of life (HRQoL) may improve treatment decision-making in patients with endometrial cancer. We investigated whether either age or comorbidity is more strongly associated with changes in HRQoL over time. Methods: Endometrial cancer patients (n = 296) were invited to complete questionnaires after initial treatment and after 6, 12 and 24 months follow-up. Patients were divided into subgroups according to age (<60, 60-75 and ≥75 years) and according to comorbidity (0, 1, 2 or ≥3). HRQoL was measured with the five EORTC QLQ-C30 functioning scales. Linear mixed models were performed for the different subgroups to assess changes in HRQoL over time. H...
Add to ORKG